Joe Fraas, MBA

Joe Fraas, MBA has a diverse and extensive work experience spanning several industries. Joe currently holds the position of Regional Sales Director at Renalytix, an artificial intelligence-enabled in vitro diagnostics company focused on optimizing clinical management of kidney disease. Prior to this, they served as the Area Sales Director - Central, US at Eurofins Transplant Genomics, where they were responsible for all sales activities in the Central region of the United States. Joe also worked as a Senior Regional Sales Manager at BioDelivery Sciences International, a specialty pharmaceutical company specializing in pain management and addiction medicine.

Before that, Joe worked as a District Sales Manager at CR Bard, where they led a team and managed sales in the urology and critical care field. Joe also held the position of Regional Sales Director at Atherotech, a cardio-diagnostic company, where they focused on direct measurement of the comprehensive lipid profile. At Thermo Fisher Scientific, they served as a District Sales Manager and a Clinical Sales Consultant, leading sales teams and selling a portfolio of products in the medical field.

Joe began their career as a Pharmaceutical Sales Representative at Cornerstone Biopharma and held business development roles at Modis and Bradford & Galt. Joe started their professional journey as an Account Executive at Susquehanna Radio. Throughout their career, they have demonstrated strong leadership, coaching, and sales skills. Joe's experience spans various sectors, including healthcare, pharmaceuticals, and technology.

Joe Fraas, MBA, obtained a Master of Business Administration (M.B.A.) degree from Baker University from 2015 to 2017. The field of study for their degree was Business Administration and Management, General. Prior to that, they attended The University of Kansas from 1995 to 1999, where they earned a Bachelor of Science (B.S.) degree in Journalism. In terms of additional certifications, Joe obtained the "Challenger Champion" certification from Eurofins Transplant Genomics in March 2023, and the "Challenger Fundamentals - Core Sales Skills" certification from Challenger in February 2023.